Phosphatase.
Phosphatases snip phosphate groups off other molecules. The intestinal type is used for gut barrier support, though how much of an oral dose survives digestion is the open question.
- Category
- Enzyme
What Phosphatase is, and what it does.
- Does it work
- Suits people exploring gut barrier support who read activity units rather than milligrams. Phytase, the plant-facing version, suits anyone eating plenty of whole grains and legumes.
- How much to take
- No daily amount is on record, and milligrams tell you little here. Enzymes are measured in activity units, so start from the unit figure printed on your product.
- Time to feel it
- Nobody has measured a time course for an oral phosphatase in people. Any effect would sit in gut and blood markers rather than in something you notice on a given day.
- The first dose
- Day one passes without a sensation attached to it. This one works at the gut wall, and what it does there shows up in laboratory measures.
- With regular use
- Weeks of daily use read out in laboratory markers of gut and bone turnover rather than in daily experience. Long-run human data on oral forms is still thin.
- How well tolerated
- Enzyme preparations are usually well tolerated. Check with your doctor first if you're pregnant, breastfeeding, or taking prescription medicines.
- How it feels
- Neutral. No taste, no warmth, no lift. The action sits at the gut lining and shows up in a laboratory measure rather than a sensation.
- The overlooked benefit
- The intestinal form strips phosphate off bacterial lipopolysaccharide, which quiets the TLR4 signal that endotoxin would otherwise set off right at the gut wall.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Dephosphorylation of bacterial lipopolysaccharide at the gut wallNarrative review
- Bone mineralisation through pyrophosphate hydrolysisNarrative review
- Serum activity as a liver and bone laboratory markerNarrative review
- Oral supplementation for gut barrier supportAnimal study
- Phytase release of phosphorus bound in plant phytateRandomised trial
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Each alkaline phosphatase active site holds two zinc ions that are directly required for hydrolysis of the phosphate ester. Without them the enzyme has no catalytic activity. This is why serum alkaline phosphatase activity falls when zinc status is poor, and it is a well characterised metalloenzyme relationship. Note the enzyme activity is a marker of zinc status, not a health outcome by itself.
Beyond the two zinc ions, alkaline phosphatase carries a magnesium site that stabilises the active conformation. Assays for the enzyme deliberately include magnesium for this reason. It is a settled cofactor relationship from enzymology. It does not follow that supplementing magnesium raises anyone's enzyme activity above normal.
Phosphorylated B6 cannot pass the intestinal membrane intact. Alkaline phosphatase on the brush border strips the phosphate, the free pyridoxal is absorbed, and the cell re-phosphorylates it inside. This is why taking the phosphorylated form does not bypass the conversion step people often expect it to. The chemistry is settled and worth knowing before paying extra for the activated form.
Dietary riboflavin arrives mostly as FMN and FAD bound to protein. Brush border phosphatases release free riboflavin, which is what the transporter carries. The same logic applies as with phosphorylated B6. It is an absorption step, not an effect on riboflavin's downstream role.
Pyrophosphate blocks hydroxyapatite crystal growth. The bone isoform of alkaline phosphatase cleaves it, which permits calcium and phosphate to be incorporated into the matrix. This is why bone-specific alkaline phosphatase is measured as a bone turnover marker. A turnover marker reports remodelling activity and is not itself a measure of bone strength.
K2 activates osteocalcin, which binds calcium in bone matrix, while alkaline phosphatase clears the pyrophosphate brake on mineralisation. The two act at different points of the same remodelling process. Studies of K2 report movement in bone alkaline phosphatase alongside other markers. Marker movement is not the same as a change in fracture risk, and the two should not be reported as one thing.
Phytase strips phosphate from phytic acid in the acidic upper gut, freeing minerals that phytate would otherwise bind. Alkaline phosphatase works at alkaline pH further down and on different phosphate esters. Formulated together they cover a wider substrate and pH range than either does alone. The two are complementary rather than interchangeable.
Intestinal alkaline phosphatase has been studied for its role at the gut barrier, and zinc carnosine is used with barrier integrity in mind while also supplying the zinc that the enzyme requires. The overlap is mechanistic and the human data for the combination is not there. Read it as a formulation rationale, not a demonstrated pairing.
Removing a phosphate group from the lipid A portion of lipopolysaccharide markedly lowers its signalling activity at TLR4. That is one reason intestinal alkaline phosphatase is studied as a regulator of the gut interface with resident bacteria. Live organisms shift the composition of that bacterial load. The combined effect in people has not been measured.
Intestinal alkaline phosphatase expression is induced by dietary fat and sits on the same brush border where bile salt micelles deliver lipid. The functions are adjacent rather than dependent. No trial has tested the pair. It is offered as physiology, not a recommendation.
Nothing specific on file for Phosphatase. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Phosphatase actually does.
These enzymes break phosphate bonds off certain molecules in an alkaline environment, and each active site needs a couple of zinc ions and one magnesium ion to work.
We make four different versions of this enzyme from separate genes, found in different tissues. A blood test result is a mix of all of them, which is why labs sometimes separate them out when it matters which tissue it's coming from.
The gut version of this enzyme strips a phosphate group off a bacterial toxin component, sharply weakening its ability to trigger an immune alarm signal.
One version of this enzyme breaks down a compound that normally puts the brakes on mineral crystal growth in bone, so removing it lets bone mineral form.
Where Phosphatase comes from.
It is an enzyme that snips phosphate groups off other molecules. It comes either from calf gut lining or from cells engineered to make the human version. Buy it by activity units, not by milligrams, because weight tells you nothing about how much work it can do.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
The traditional source is bovine intestinal scrapings. The modern alternative is a human-sequence gene expressed in a cultured host.
Alkaline phosphatase is membrane-anchored through a GPI link, so a detergent or phospholipase step is needed to release it.
Ion exchange and affinity steps separate the enzyme from other mucosal proteins.
Batches are specified in enzyme activity units per gram, not milligrams of protein. Two products of the same weight can differ several-fold in activity.
Freeze-dried and stabilised, then coated when the target is the small intestine.
Getting Phosphatase from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Reviews the case for supplementing intestinal alkaline phosphatase as a way of supporting gut barrier function.Narrative review. Fujita et al., 2016 (Journal of the American College of Surgeons). PMID 27687841 ↗
- Summarises alkaline phosphatase as a constituent of milk and its proposed protective role at the infant intestinal barrier.Narrative review. Wu et al., 2022 (Foods). PMID 35563935 ↗
- Reports that supplemental intestinal alkaline phosphatase supported intestinal barrier measures and interacted with the bacterial lipopolysaccharide signal.In vitro study. Gao et al., 2024 (Journal of Agricultural and Food Chemistry). PMID 37964463 ↗
- Alkaline phosphatase added during machine perfusion improved metabolic measures in the perfused organ.In vitro study. Steenvoorden et al., 2026 (Transplantation Direct). PMID 41799024 ↗
These are the studies our verdict leans on, chosen from the 4 we read for Phosphatase. The full linked list is below.
The studies, linked.
4 sources behind our Phosphatase verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialA Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] PathwayClinicalTrials.gov ↗Phase 2, 69 participants, Completed
- Clinical trialEvaluation Of Gingival Crevicular Fluid And Salivary Ferritin, Alkaline Phosphatase And Matrix Metalloproteinase-8 Levels Of Individuals With Different Periodontal DiseasesClinicalTrials.gov ↗60 participants, Completed
- Clinical trialSearch Elevated Serum Alkaline Phosphatase as a Marker of Prenatal Intervillositis Chronic Histiocytic (IHC)ClinicalTrials.gov ↗54 participants, Completed
- Clinical trialPhase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP) and Nivolumab in Patients With Non-Metastatic, PSA-Recurrent Prostate CancerClinicalTrials.gov ↗Phase 2, 19 participants, Active not recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 113 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Phosphatase is, not how risky it is. A report is not proof Phosphatase caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.